Skip to main content

AMERIPRISE FINANCIAL INC

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 820027 MINNEAPOLIS, MN

Position in MDGL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$124,145,521
+$72,750,717 QoQ
Shares Held
231,205
+135.5% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#21
of 402 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 98% None 2%

Common Shares in MDGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. MDGL ranks #7 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 MDGL
Madrigal Pharmaceuticals, Inc.
This page
231,205 $124,145,521

All Filings in MDGL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $124,145,521 231,205
2026-03-31 $51,394,804 98,181
2025-12-31 $17,054,989 29,287
2025-09-30 $5,961,201 12,997
2025-06-30 $2,543,990 8,406
2025-03-31 $1,654,161 4,994
2024-12-31 $2,674,683 8,668
2024-09-30 $7,992,203 37,660
2024-06-30 $423,321 1,511
2024-03-31 $430,734 1,613
2023-12-31 $1,175,178 5,079
2023-09-30 $739,400 5,063
2023-06-30 $1,551,627 6,717
2023-03-31 $317,602 1,311
2022-12-31 $415,347 1,431